Chau T Dang

13PUBLICATIONS
85CO-AUTHORS
Environmental epidemiologyPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsEpidemiological methods
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|May 05, 2026
Benralizumab for Eosinophil-Related Cutaneous Adverse Events of Anticancer Therapy: A Phase II Trial.

|Oct 29, 2024
Invasive disease-free survival and brain metastasis rates in patients treated with neoadjuvant chemotherapy with trastuzumab and pertuzumab.

S M Chew, E Ferraro, Y Chen

|Oct 18, 2024
Predictors of response to CDK4/6i retrial after prior CDK4/6i failure in ER+ metastatic breast cancer.

Nicholas Mai, Carlos H Dos Anjos, Pedram Razavi

|May 15, 2024
Predictors of Response to CDK4/6i Retrial After Prior CDK4/6i Failure in ER+ Metastatic Breast Cancer.

Nicholas Mai, Carlos H Dos Anjos, Pedram Razavi

|Sep 26, 2023
Nomogram for Predicting Risk of Cancer Therapy-Related Cardiac Dysfunction in Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer.

Anthony F Yu, I-Hsin Lin, Justine Jorgensen

|May 01, 2023
Cytochrome P450 Oxidoreductase (POR) Associated with Severe Paclitaxel-Induced Peripheral Neuropathy in Patients of European Ancestry from ECOG-ACRIN E5103.

Fei Shen, Guanglong Jiang, Santosh Philips

Pageof 3

Frequent Collaborators

5 joint publications

Mark Robson

4 joint publications

Pedram Razavi

3 joint publications

Sarat Chandarlapaty

3 joint publications

Antonio C Wolff